Where is Selank being studied?

Find registered human studies, phases, products, recruitment status and reported research locations around the world. Registry search matches are separate from this profile’s reviewed evidence.

Scientific intelligence record

Experience 2.0

Synthetic regulatory peptide

Selank

Synthetic tuftsin-derived heptapeptide studied primarily in Russian-language preclinical and clinical literature.

Record status

Traceability partial

Last meaningful update: 9/20/2026

Evidence searched through:
Not recorded
Assessment updated:
9/20/2026
Documented human review:
No documented human review recorded
Automated scientific assessment:
None recorded
AI source check:
9/26/2026

Published source links and profile text pass separate gates. Only a documented human review is labelled as human review; an automated scientific assessment applies deterministic checks, and an AI source check confirms only that a source exists and matches its identifiers. A source count alone does not establish a review.

Evidence coverage has three distinct layers. The corpus count is a transparent screening inventory, the featured set contains study-level tiering and interpretation, and the published-source count contains records promoted through the institutional publication workflow. Source validation, editorial publication, and scientific appraisal are separate decisions; these numbers must not be merged.

Ranked research corpus

116

Categorized publications with provisional ranking; scientific review remains separate.

Featured tiered studies

0

Cornerstone publications with study-level interpretation, limitations, and tier disclosure.

Research domains

4

Clinical and scientific questions synthesized independently across the evidence atlas.

Published source records

28

Database records promoted through the governed publication workflow—not the corpus total.

Corpus generated 2026-09-18. Counts remain separately labeled so screening is not represented as completed review.

Human experience · separate evidence stream

No community pattern is displayed yet

Eligible observations remain below the privacy and reliability threshold. WPF will not convert a handful of reports into a percentage, trend, or clinical claim.

Observation is valuable human context. It is not evidence of causation, efficacy, or safety.

Public display gate

n ≥ 20 eligible observations

Exact progress remains private before the threshold.

Intelligence snapshot

The state of the record

A compact view of what is represented, what remains unresolved, and how completely the record can be traced.

Ranked research corpus

116

Categorized screening records; proposed rankings remain pending human appraisal.

Featured tiered studies

0

Cornerstone studies with published study-level interpretation and tier disclosure.

Research domains

4

Independent evidence dossiers covering the major research questions.

Published source records

28

Source records published through the governed workflow; this count does not certify scientific conclusions.

Contradictions

0

Conflicting evidence relationships that remain visible.

Research gaps

1

Questions the current record identifies as unresolved.

Connected media

0

Media records explicitly linked to this scientific record.

What we know

Evidence, claims, and boundaries

The project separates represented evidence from qualification, contradiction, uncertainty, and what the evidence does not establish.

Reconciled domain conclusions

4 published domain syntheses connected to 0 featured studies

Selank no longer relies on the legacy “no public claim” state. Each research domain publishes a bounded synthesis, confidence level, evidence context, limitations, geographic applicability, regulatory interpretation, and research gaps. Publication of these syntheses is separate from the scientific review status shown above.

Inspect the reconciled evidence atlas
Inspect the published evidence record28 governed records · titles, provenance, and original-source linksOpen records ↓
2014Phase 1–2 human evidence

[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].

PubMed-indexed clinical trial; comparative study; journal article examining [a comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
V E Medvedev; O N Tereshchenko; A Iu Israelian; I K Chobanu; N V Kost; O Iu Sokolov; N F Miasoedov
Source
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
PubMed
25176261
Open original source
2026Observational human evidence

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

PubMed-indexed journal article; review examining therapeutic peptides in orthopaedics: applications, challenges, and future directions. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
Omar F Rahman; Steven J Lee; William A Seeds
Source
Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews
DOI
10.4155/fdd-2022-0009
PubMed
41490200
Open original source
2017Observational human evidence

Anticoagulant Effects of Arginine-Containing Peptides of the Glyproline Family (His-Phe-Arg-Trp-Pro-Gly-Pro and Thr-Lys-Pro-Arg-Pro-Gly-Pro) Revealed by Thromboelastography.

PubMed-indexed journal article examining anticoagulant effects of arginine-containing peptides of the glyproline family (his-phe-arg-trp-pro-gly-pro and thr-lys-pro-arg-pro-gly-pro) revealed by thromboelastography. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
E Ya Rogozinskaya; M G Lyapina
Source
Bulletin of experimental biology and medicine
DOI
10.1007/s10517-017-3950-4
PubMed
29181670
Open original source
2020Observational human evidence

Functional Connectomic Approach to Studying Selank and Semax Effects.

PubMed-indexed journal article examining functional connectomic approach to studying selank and semax effects. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
Ya R Panikratova; I S Lebedeva; O Yu Sokolov; A D Rumshiskaya; D A Kupriyanov; N V Kost; N F Myasoedov
Source
Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections
DOI
10.1134/S001249662001007X
PubMed
32342318
Open original source
2017Observational human evidence

Tuftsin - Properties and Analogs.

PubMed-indexed journal article; review examining tuftsin - properties and analogs. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
Agnieszka Siebert; Monika Gensicka-Kowalewska; Grzegorz Cholewinski; Krystyna Dzierzbicka
Source
Current medicinal chemistry
DOI
10.2174/0929867324666170725140826
PubMed
28745220
Open original source
2021Observational human evidence

The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress.

PubMed-indexed journal article; research support, non-u.s. gov't examining the influence of selank on the level of cytokines under the conditions of "social" stress. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
Yasenyavskaya A Leonidovna; Samotrueva M Aleksandrovna; Tsibizova A Aleksandrovna; Bashkina O Aleksandrovna; Myasoedov N Fedorovich; Andreeva L Aleksandrovna
Source
Current reviews in clinical and experimental pharmacology
DOI
10.2174/1574884715666200704152810
PubMed
32621722
Open original source
2020Observational human evidence

The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind.

PubMed-indexed journal article examining the occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: an incentive for controlling agencies to prepare for future encounters of the kind. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
Celine Vanhee; Antoine Francotte; Steven Janvier; Eric Deconinck
Source
Drug testing and analysis
DOI
10.1002/dta.2717
PubMed
31667971
Open original source
2010Observational human evidence

[Experimental optimization of learning and memory processes by selank].

PubMed-indexed journal article examining [experimental optimization of learning and memory processes by selank]. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
T P Semenova; I I Kozlovskiĭ; N M Zakharova; M M Kozlovskaia
Source
Eksperimental'naia i klinicheskaia farmakologiia
PubMed
20919548
Open original source
2008Observational human evidence

[Immunomodulatory effects of selank in patients with anxiety-asthenic disorders].

PubMed-indexed comparative study; journal article examining [immunomodulatory effects of selank in patients with anxiety-asthenic disorders]. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
O N Uchakina; P N Uchakin; N F Miasoedov; L A Andreeva; V E Shcherbenko; M V Mezentseva; M V Gabaeva; O Iu Sokolov; A A Zozulia; F I Ershov
Source
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
PubMed
18577961
Open original source
2013Observational human evidence

[Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank].

PubMed-indexed journal article examining [transcriptome alteration in hippocampus under the treatment of tuftsin analog selank]. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
T A Kolomin; T Iu Agapova; Ia V Agniullin; S I Shram; M I Shadrina; P A Slominskiĭ; S A Limborskaia; I F Miasoedov
Source
Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova
DOI
10.7868/s0044467713030052
PubMed
24450168
Open original source
2016Observational human evidence

Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission.

PubMed-indexed journal article examining selank administration affects the expression of some genes involved in gabaergic neurotransmission. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
Anastasiya Volkova; Maria Shadrina; Timur Kolomin; Lyudmila Andreeva; Svetlana Limborska; Nikolay Myasoedov; Petr Slominsky
Source
Frontiers in pharmacology
DOI
10.1134/S1068162006020099
PubMed
26924987
Open original source
2018Observational human evidence

Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.

PubMed-indexed journal article examining peptide-based anxiolytics: the molecular aspects of heptapeptide selank biological activity. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
Tatiana V Vyunova; Lioudmila Andreeva; Konstantin Shevchenko; Nikolay Myasoedov
Source
Protein and peptide letters
DOI
10.2174/0929866525666180925144642
PubMed
30255741
Open original source
2014Observational human evidence

The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action.

PubMed-indexed journal article; research support, non-u.s. gov't examining the temporary dynamics of inflammation-related genes expression under tuftsin analog selank action. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
Timur Kolomin; Marina Morozova; Anastasiya Volkova; Maria Shadrina; Lyudmila Andreeva; Petr Slominsky; Svetlana Limborska; Nikolay Myasoedov
Source
Molecular immunology
DOI
10.1016/j.molimm.2013.11.002
PubMed
24291245
Open original source
2003Animal research

The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats.

PubMed-indexed comparative study; journal article; research support, non-u.s. gov't examining the optimizing action of the synthetic peptide selank on a conditioned active avoidance reflex in rats. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
I I Kozlovskii; N D Danchev
Source
Neuroscience and behavioral physiology
DOI
10.1023/a:1024444321191
PubMed
14552529
Open original source
2019Animal research

Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.

PubMed-indexed journal article examining selank, peptide analogue of tuftsin, protects against ethanol-induced memory impairment by regulating of bdnf content in the hippocampus and prefrontal cortex in rats. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
L G Kolik; A V Nadorova; T A Antipova; S V Kruglov; V S Kudrin; A D Durnev
Source
Bulletin of experimental biology and medicine
DOI
10.1007/s10517-019-04588-9
PubMed
31625062
Open original source
2009Animal research

[Comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats pretreated with PCPA].

PubMed-indexed comparative study; journal article examining [comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats pretreated with pcpa]. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
T P Semenova; I I kozlovskiĭ; N M Zakharova; M M Kozlovskaia
Source
Eksperimental'naia i klinicheskaia farmakologiia
PubMed
19803361
Open original source
2014Animal research

[Effect of tripeptide Pro-Gly-Pro on rat brain transcriptome in focal ischemia].

PubMed-indexed english abstract; journal article; research support, non-u.s. gov't examining [effect of tripeptide pro-gly-pro on rat brain transcriptome in focal ischemia]. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
E V Medvedeva; V G Dmitrieva; O V Povarova; S A Limborskaia; V I Skvortsova; N F Miasoedov; L V Dergunova
Source
Molekuliarnaia biologiia
PubMed
25850296
Open original source
2017Animal research

Studying the Toxic Effects of Some Biologically Active Peptides on the Model of Mouse Embryonic Stem Cells.

PubMed-indexed journal article examining studying the toxic effects of some biologically active peptides on the model of mouse embryonic stem cells. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
A G Kobylyanskii; Yu A Zolotarev; L A Andreeva; I A Grivennikov; N F Myasoedov
Source
Bulletin of experimental biology and medicine
DOI
10.1007/s10517-017-3891-y
PubMed
29063333
Open original source
2019Animal research

State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment.

PubMed-indexed journal article examining state of colon microbiota in rats during chronic restraint stress and selank treatment. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
A Yu Mukhina; O A Medvedeva; M V Svishcheva; A V Shevchenko; N N Efremova; I I Bobyntsev; P V Kalutskii; L A Andreeva; N F Myasoedov
Source
Bulletin of experimental biology and medicine
DOI
10.1007/s10517-019-04496-y
PubMed
31236882
Open original source
2017Animal research

Effect of Selank on Spontaneous Synaptic Activity of Rat Hippocampal CA1 Neurons.

PubMed-indexed journal article examining effect of selank on spontaneous synaptic activity of rat hippocampal ca1 neurons. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
I S Povarov; R V Kondratenko; V I Derevyagin; N F Myasoedov; V G Skrebitsky
Source
Bulletin of experimental biology and medicine
DOI
10.1007/s10517-017-3676-3
PubMed
28361410
Open original source
2020Animal research

Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank.

PubMed-indexed journal article examining morphological changes in the large intestine of rats subjected to chronic restraint stress and treated with selank. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
A Yu Mukhina; E S Mishina; I I Bobyntsev; O A Medvedeva; M V Svishcheva; P V Kalutskii; L A Andreeva; N F Myasoedov
Source
Bulletin of experimental biology and medicine
DOI
10.1007/s10517-020-04868-9
PubMed
32651826
Open original source
2016Animal research

[COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND INTRAPERITONEAL ADMINISTRATION TO BALB/c AND C57BL/6 MICE.].

PubMed-indexed comparative study; journal article examining [comparison of pharmacological effects of heptapeptide selank after intranasal and intraperitoneal administration to balb/c and c57bl/6 mice.]. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
E V Vasil'eva; E A Kondrakhin; R M Salimov; G I Kovalev
Source
Eksperimental'naia i klinicheskaia farmakologiia
PubMed
29787664
Open original source
2019Animal research

Effect of Selank on Morphological Parameters of Rat Liver in Chronic Foot-Shock Stress.

PubMed-indexed journal article examining effect of selank on morphological parameters of rat liver in chronic foot-shock stress. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
E V Fomenko; I I Bobyntsev; A V Ivanov; A E Belykh; L A Andreeva; N F Myasoedov
Source
Bulletin of experimental biology and medicine
DOI
10.1007/s10517-019-04512-1
PubMed
31243679
Open original source
2011Animal research

Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank.

PubMed-indexed journal article; research support, non-u.s. gov't examining expression of inflammation-related genes in mouse spleen under tuftsin analog selank. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
Timur Kolomin; Maria Shadrina; Lyudmila Andreeva; Petr Slominsky; Svetlana Limborska; Nikolay Myasoedov
Source
Regulatory peptides
DOI
10.1016/j.regpep.2011.05.001
PubMed
21609736
Open original source
2017Animal research

Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats.

PubMed-indexed journal article examining peptide selank enhances the effect of diazepam in reducing anxiety in unpredictable chronic mild stress conditions in rats. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
Anastasiya Kasian; Timur Kolomin; Lyudmila Andreeva; Elena Bondarenko; Nikolay Myasoedov; Petr Slominsky; Maria Shadrina
Source
Behavioural neurology
DOI
10.17116/jnevro20151156133-40
PubMed
28280289
Open original source
2017Animal research

Effect of Selank on Functional State of Rat Hepatocytes under Conditions of Restraint Stress.

PubMed-indexed journal article examining effect of selank on functional state of rat hepatocytes under conditions of restraint stress. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
E V Fomenko; I I Bobyntsev; A A Kryukov; A V Ivanov; L A Andreeva; N F Myasoedov
Source
Bulletin of experimental biology and medicine
DOI
10.1007/s10517-017-3817-8
PubMed
28853100
Open original source
2017Laboratory research

GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells.

PubMed-indexed journal article examining gaba, selank, and olanzapine affect the expression of genes involved in gabaergic neurotransmission in imr-32 cells. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
Elena Filatova; Anastasiya Kasian; Timur Kolomin; Ekaterina Rybalkina; Anelya Alieva; Lyudmila Andreeva; Svetlana Limborska; Nikolay Myasoedov; Galina Pavlova; Petr Slominsky; Maria Shadrina
Source
Frontiers in pharmacology
DOI
10.1016/0014-2999(96)00066-0
PubMed
28293190
Open original source
2006Laboratory research

[Evenly tritium-labeled peptides and their in vivo and in vitro biodegradation].

PubMed-indexed journal article examining [evenly tritium-labeled peptides and their in vivo and in vitro biodegradation]. Machine-staged source candidate; findings and limitations require accountable review before publication.

Authors
Iu A Zolotarev; A K Dadaian; O V Dolotov; V S Kozik; N V Kost; O Iu Sokolov; E M Dorokhova; V K Meshavkin; L S Inozemtseva; M V Gabaeva; L A Andreeva; L Iu Alfeeva
Source
Bioorganicheskaia khimiia
PubMed
16637290
Open original source

Scientific context

Chemistry and represented biological context

Existing reviewed chemistry is preserved as scientific context. Chemistry and mechanism information do not establish clinical efficacy or safety.

Open chemistry and biological context ↓
Chemical identity

Molecular and structural record

Structured record
Molecular formula
C33H57N11O9
Molecular weight (Da)
751.9
Amino acid sequence
TKPRPGP
InChIKey
JTDTXGMXNXBGBZ-YVQNUOSGSA-N

Chemical identity describes the recorded molecular information. It does not establish biological activity, clinical efficacy, safety, or therapeutic suitability.

Research

How the scientific record is developing

Chronology, unresolved research questions, opportunities, and researcher activity remain descriptive rather than evaluative.

Research chronology

  1. 2003 · study · Temporal status not established

    The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats.

    Neuroscience and behavioral physiology

  2. 2006 · study · Temporal status not established

    [Evenly tritium-labeled peptides and their in vivo and in vitro biodegradation].

    Bioorganicheskaia khimiia

  3. 2008 · study · Temporal status not established

    [Immunomodulatory effects of selank in patients with anxiety-asthenic disorders].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

  4. 2009 · study · Temporal status not established

    [Comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats pretreated with PCPA].

    Eksperimental'naia i klinicheskaia farmakologiia

  5. 2010 · study · Temporal status not established

    [Experimental optimization of learning and memory processes by selank].

    Eksperimental'naia i klinicheskaia farmakologiia

  6. 2011 · study · Temporal status not established

    Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank.

    Regulatory peptides

  7. 2013 · study · Temporal status not established

    [Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank].

    Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova

  8. 2014 · study · Temporal status not established

    [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

  9. 2014 · study · Temporal status not established

    The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action.

    Molecular immunology

  10. 2014 · study · Temporal status not established

    [Effect of tripeptide Pro-Gly-Pro on rat brain transcriptome in focal ischemia].

    Molekuliarnaia biologiia

  11. 2016 · study · Temporal status not established

    Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission.

    Frontiers in pharmacology

  12. 2016 · study · Temporal status not established

    [COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND INTRAPERITONEAL ADMINISTRATION TO BALB/c AND C57BL/6 MICE.].

    Eksperimental'naia i klinicheskaia farmakologiia

  13. 2017 · study · Temporal status not established

    Anticoagulant Effects of Arginine-Containing Peptides of the Glyproline Family (His-Phe-Arg-Trp-Pro-Gly-Pro and Thr-Lys-Pro-Arg-Pro-Gly-Pro) Revealed by Thromboelastography.

    Bulletin of experimental biology and medicine

  14. 2017 · study · Temporal status not established

    Tuftsin - Properties and Analogs.

    Current medicinal chemistry

  15. 2017 · study · Temporal status not established

    Studying the Toxic Effects of Some Biologically Active Peptides on the Model of Mouse Embryonic Stem Cells.

    Bulletin of experimental biology and medicine

  16. 2017 · study · Temporal status not established

    Effect of Selank on Spontaneous Synaptic Activity of Rat Hippocampal CA1 Neurons.

    Bulletin of experimental biology and medicine

  17. 2017 · study · Temporal status not established

    Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats.

    Behavioural neurology

  18. 2017 · study · Temporal status not established

    Effect of Selank on Functional State of Rat Hepatocytes under Conditions of Restraint Stress.

    Bulletin of experimental biology and medicine

  19. 2017 · study · Temporal status not established

    GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells.

    Frontiers in pharmacology

  20. 2018 · study · Temporal status not established

    Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.

    Protein and peptide letters

  21. 2019 · study · Temporal status not established

    Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.

    Bulletin of experimental biology and medicine

  22. 2019 · study · Temporal status not established

    State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment.

    Bulletin of experimental biology and medicine

  23. 2019 · study · Temporal status not established

    Effect of Selank on Morphological Parameters of Rat Liver in Chronic Foot-Shock Stress.

    Bulletin of experimental biology and medicine

  24. 2020 · study · Temporal status not established

    Functional Connectomic Approach to Studying Selank and Semax Effects.

    Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections

  25. 2020 · study · Temporal status not established

    The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind.

    Drug testing and analysis

  26. 2020 · study · Temporal status not established

    Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank.

    Bulletin of experimental biology and medicine

  27. 2021 · study · Temporal status not established

    The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress.

    Current reviews in clinical and experimental pharmacology

  28. 2026 · study · Temporal status not established

    Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

    Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews

  29. 2026 · regulatory · Temporal status not established

    Regulatory review: not_approved

    European Union

  30. 2026 · regulatory · Temporal status not established

    Regulatory review: not_approved

    United States

The represented chronology reflects records currently included in the governed dataset and does not claim to represent the entire scientific literature.

What still needs investigation

Claim traceability

No institutional claim record is currently represented for this peptide.

Evidence is missing or not represented as studied; this is not a conclusion that the intervention does not work.

Researchers represented in the evidence record12 bibliographic identities · open to inspect

These are bibliographic author identities derived from represented records. Name strings are not proof of unique real-world researcher identity, and publishing organizations are not treated as institutional affiliations.

L A Andreeva

7 represented evidence records

Years represented: 2006, 2008, 2017, 2019, 2020

Publishing organizations appearing in records: Bioorganicheskaia khimiia, Bulletin of experimental biology and medicine, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Nikolay Myasoedov

6 represented evidence records

Years represented: 2011, 2014, 2016, 2017, 2018

Publishing organizations appearing in records: Behavioural neurology, Frontiers in pharmacology, Molecular immunology, Protein and peptide letters, Regulatory peptides

Lyudmila Andreeva

5 represented evidence records

Years represented: 2011, 2014, 2016, 2017

Publishing organizations appearing in records: Behavioural neurology, Frontiers in pharmacology, Molecular immunology, Regulatory peptides

Maria Shadrina

5 represented evidence records

Years represented: 2011, 2014, 2016, 2017

Publishing organizations appearing in records: Behavioural neurology, Frontiers in pharmacology, Molecular immunology, Regulatory peptides

Petr Slominsky

5 represented evidence records

Years represented: 2011, 2014, 2016, 2017

Publishing organizations appearing in records: Behavioural neurology, Frontiers in pharmacology, Molecular immunology, Regulatory peptides

Svetlana Limborska

4 represented evidence records

Years represented: 2011, 2014, 2016, 2017

Publishing organizations appearing in records: Frontiers in pharmacology, Molecular immunology, Regulatory peptides

Timur Kolomin

5 represented evidence records

Years represented: 2011, 2014, 2016, 2017

Publishing organizations appearing in records: Behavioural neurology, Frontiers in pharmacology, Molecular immunology, Regulatory peptides

I I Bobyntsev

4 represented evidence records

Years represented: 2017, 2019, 2020

Publishing organizations appearing in records: Bulletin of experimental biology and medicine

N F Myasoedov

7 represented evidence records

Years represented: 2017, 2019, 2020

Publishing organizations appearing in records: Bulletin of experimental biology and medicine, Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections

N V Kost

3 represented evidence records

Years represented: 2006, 2014, 2020

Publishing organizations appearing in records: Bioorganicheskaia khimiia, Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

O Iu Sokolov

3 represented evidence records

Years represented: 2006, 2008, 2014

Publishing organizations appearing in records: Bioorganicheskaia khimiia, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

A V Ivanov

2 represented evidence records

Years represented: 2017, 2019

Publishing organizations appearing in records: Bulletin of experimental biology and medicine

Connections

Follow the scientific relationships

Connections appear only when they are represented by the project’s underlying records.

Open 12 represented connections ↓

institution

Bulletin of experimental biology and medicine

represented evidence source

institution

Eksperimental'naia i klinicheskaia farmakologiia

represented evidence source

institution

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

represented evidence source

institution

Frontiers in pharmacology

represented evidence source

institution

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews

represented evidence source

institution

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections

represented evidence source

institution

Current medicinal chemistry

represented evidence source

institution

Current reviews in clinical and experimental pharmacology

represented evidence source

institution

Drug testing and analysis

represented evidence source

institution

Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova

represented evidence source

institution

Protein and peptide letters

represented evidence source

institution

Molecular immunology

represented evidence source

Traceability

Follow the record back to its source

The experience makes incomplete links visible instead of presenting a false impression of perfect provenance.

Source publication state

A governed source may be verified and approved for publication while its claim-to-evidence link is still incomplete.

Reviewer provenance state

“Human scientist reviewed: no” means that specific source-path attribution is not recorded. It does not silently negate the separate publication-review state.

Domain conclusion → Evidence

Connected

Evidence → Source

Connected

Source → Original record

Connected

Traceability documents how the project connects statements to records. It does not establish that a source is scientifically valid or that a claim is clinically true.

Reconciled for 4 domain conclusions and 0 featured studies.

Detailed study-to-domain mappings and original-source paths appear in the Selank evidence-governance section.

Inspect the ranked source records

Observational archive

What contributors reported

Observational archive data is intentionally separated from published scientific evidence.

Observational boundary

Insufficient eligible observations are available for display under the current filters.

Insufficient eligible observations are currently represented to display aggregated findings for this peptide.

Regulatory context

Published jurisdictional records

Regulatory status is jurisdiction-specific and time-dependent. It is presented as context, not as a recommendation for use or a substitute for scientific evidence evaluation.

European Union

Regulator: Not represented

not_approved

As of: 9/9/2026 · Temporal status not established

Regulatory context incomplete: regulator.

EMA medicines portal

United States

Regulator: Not represented

not_approved

As of: 9/9/2026 · Temporal status not established

Regulatory context incomplete: regulator.

FDA compounding safety-risk list

Research + media

Media connected to this scientific record

Only media explicitly linked through the project’s relationship system appears here.

No scientifically connected media is currently represented for this peptide.

Sources + provenance

Read the scientific record with its boundaries intact

The public record organizes reviewed evidence; it does not establish scientific truth by itself.
Association, mechanism, observation and regulatory status must not be represented as proof of clinical efficacy or safety.
Observational reports describe contributor experiences and cannot establish causation, effectiveness, safety or clinical benefit.
Contradictory and qualifying evidence must remain visible rather than being silently discarded.
Absence of represented evidence is not evidence that research does not exist.
Research gaps identify unresolved questions; they are not negative conclusions.
Regulatory status is distinct from scientific evidence quality.
Media relationships provide context and explanation; they do not increase the strength of scientific evidence.
A section with no represented records is an incomplete project record, not a scientific conclusion.
Researcher and institutional relationships are shown only when supported by represented records and must not be interpreted as rankings or endorsements.

Generated: 11/8/2026, 5:24:44 PM

global evidence atlas

Selank research, ranked and separated by purpose

This is a deduplicated literature screening registry—not a claim that every mention directly proves efficacy or safety. Machine proposals remain visibly separate from governed human appraisal.

116Discoverable source universe
116Ranked screening records
4Research domains
0Accountably approved conclusions

116 matching records · ranked 2026-09-18

Page 1 of 5

Count reconciliation: 116 discoverable source records match the peptide identity query; 116 are retained in this bounded, ranked screening view; 0 belong to the separate governed layer labeled “Accountably approved conclusions.” Domain totals overlap because one publication may inform several questions.

governance and regulatory context

Selank: what this atlas does and does not establish

Last checked
2026-09-18
Accountable publication approval
Not yet approved by a named accountable reviewer. Machine screening only.

No new outcome conclusion is inferred from discovery metadata. Named accountable approval is required for governed scientific conclusions.

Regulatory status by jurisdiction

Absence of a record in this pass is not proof that no authorization exists. Status must remain jurisdiction-, product-, formulation-, and date-specific.

Known limitations of this pass

  • no patent candidate retained after literal filter

No machine-proposed evidence-strength grades exist yet for this compound; all screening records are unassigned pending further review. 1 correction(s) have been recorded against this atlas's source metadata.

Selank evidence · ranking key

How evidence is ranked

A tier describes the evidentiary role and design strength of a source. It is not a popularity score, proof that every conclusion is correct, or a substitute for claim-level review.

A

Practice-defining evidence

Large, well-conducted randomized trials; prespecified major outcomes; rigorous systematic reviews or meta-analyses; and major regulatory assessments.

B

Strong supporting evidence

Smaller randomized trials, strong prospective cohorts, prespecified secondary analyses, and high-quality comparative-effectiveness studies.

C

Contextual evidence

Retrospective cohorts, claims-database studies, pharmacovigilance analyses, mechanistic human research, and well-documented case series.

D

Signal-generating evidence

Case reports, conference abstracts, preclinical research, hypothesis-generating analyses, and expert commentary.

Tier and confidence answer different questions

Tier classifies source design and evidentiary role. Confidence reflects risk of bias, sample size, comparator quality, outcome relevance, follow-up, missing data, directness, replication, reporting quality, and whether conclusions stay within the measured results.

Funding and conflicts are disclosed and considered, but sponsorship never automatically changes a tier. Corrections, retractions, and expressions of concern override the original rating.

Suggested citation

  • APA

    World Peptide Foundation. (n.d.). Selank — Peptide Scientific Intelligence. World Peptide Foundation. (Updated September 20, 2026.) https://www.worldpeptidefoundation.org/directory/selank

  • AMA / Vancouver

    World Peptide Foundation. Selank — Peptide Scientific Intelligence. World Peptide Foundation website. Updated September 20, 2026. https://www.worldpeptidefoundation.org/directory/selank